In Vitro analysis compares the efficacy of biomimetic agents and sodium fluoride on enamel lesions, showing significant improvements.
This study aimed to evaluate and compare the remineralizing efficacy of four contemporary biomimetic agents—Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP), Functionalized Tricalcium Phosphate (f-TCP), Nano-Hydroxyapatite (n-HAp), and Nano-Bioactive Glass (n-BAG)—against a standard sodium fluoride (NaF) control and a negative control using a standardized pH-cycling model on primary tooth enamel. One hundred fifty enamel slabs were prepared from non-carious human primary molars. After baseline assessments of surface microhardness (Vickers Hardness Number, VHN) and elemental composition (Ca/P ratio via EDX), artificial caries-like lesions were created. Samples were randomly allocated into six groups (n=25) for a 21-day pH-cycling regimen. Treatment groups received daily applications of their respective agent, while the negative control received deionized water. Post-treatment, microhardness, EDX, and scanning electron microscopy (SEM) were repeated. Demineralization significantly reduced microhardness and Ca/P ratios in all groups (p<0.0001). After pH-cycling, all biomimetic agents significantly outperformed the NaF and negative controls (p<0.05). The negative control showed minimal recovery. NaF improved surface hardness but did not reach baseline levels. The biomimetic agents showed superior and deeper remineralization. n-BAG and n-HAp groups achieved VHN and Ca/P ratios statistically equivalent to sound enamel baseline (p>0.05), indicating near-complete recovery. CPP-ACP was significantly more effective than f-TCP (p<0.05). SEM revealed a dense, homogenous, well-integrated mineral layer for n-HAp and n-BAG, contrasting with the partially occluding deposits of other groups. Contemporary biomimetic remineralization agents, specifically n-BAG and n-HAp, were significantly more effective than traditional sodium fluoride in repairing artificial enamel lesions on primary teeth under in vitro conditions. The efficacy hierarchy was n-BAG ≈ n-HAp > CPP-ACP > f-TCP > NaF.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: